Notably, IL-33 has been implicated in neuroinflammation across a range of neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), schizophrenia, and central nervous system injury (CNSi). This evidence concerns the gene IL33 and myeloid sarcoma.